Showing posts with the label Basilea Pharmaceutica

Basilea announces approval of antibiotic Zevtera® in China to treat community-acquired pneumonia and hospital-acquired pneumonia

Basilea Pharmaceutica announced today that its license partner Shenzhen China Resources Gosun Pharmaceuticals Co. Ltd has received a Drug Approval License from the National Medical Products Administr…

Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric cancer

Basilea Pharmaceutica announced today that it has entered into a clinical trial collaboration and supply agreement with Eli Lilly and Company for the use of the anti-VEGFR2 antibody ramucirumab (CYRA…
Subscribe Our Newsletter